Debra Jaliman - Dermatology | Mount Sinai

About Me

Debra Jaliman, MD, is a Board Certified Dermatologist with a private practice on 5th Avenue (Upper East Side) between 74th and 75th Street in Manhattan, New York. Her New York City dermatology practice focuses on cosmetic dermatology and general dermatology. The NYC dermatologist is also an Assistant Clinical Professor of Dermatology at Mt. Sinai School of Medicine in New York City. All procedures are performed at the dermatologist's state of the art fully accredited dermatology suite in Manhattan, New York.

Language

English

Position

ASSISTANT CLINICAL PROFESSOR | Dermatology

Hospital Affiliations

Mount Sinai Queens
The Mount Sinai Hospital

About Me

Debra Jaliman, MD, is a Board Certified Dermatologist with a private practice on 5th Avenue (Upper East Side) between 74th and 75th Street in Manhattan, New York. Her New York City dermatology practice focuses on cosmetic dermatology and general dermatology. The NYC dermatologist is also an Assistant Clinical Professor of Dermatology at Mt. Sinai School of Medicine in New York City. All procedures are performed at the dermatologist's state of the art fully accredited dermatology suite in Manhattan, New York.

Language

English

Position

ASSISTANT CLINICAL PROFESSOR | Dermatology

Hospital Affiliations

Mount Sinai Queens
The Mount Sinai Hospital

Clinical Focus

Acne
Actinic Keratosis
Basal Cell Carcinoma
Birthmarks
Botulinum Toxin
Cold Sores
Eczema
Genital Herpes
Melanoma

Education

MD, SUNY Downstate Health Sciences University - College of Medicine

Internship, Internal Medicine

Kaiser Foundation Hospital-San Francisco

Residency, Dermatology

Mount Sinai Hospital

Certifications

American Board of Dermatology

Locations

931 Fifth Avenue, New York, NY, 10021

212-517-8855

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

931 Fifth Avenue, New York, NY, 10021

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

View All Publications

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Jaliman did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.